Marc L. Harrison
Consigliere Generale presso NANTHEALTH, INC.
Provenienza dei contatti di primo grado di Marc L. Harrison
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Packaged Software | 11 | |
| Public Company | Pharmaceuticals: Major | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Marc L. Harrison tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Fresenius Kabi Pharmaceuticals Holding LLC
 Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| OPTINOSE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Venatorx Pharmaceuticals, Inc.
 Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Chairman | |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | President | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree | |
| California State University-Fullerton | College/University | Undergraduate Degree | |
| CVRX, INC. | Medical Specialties | Director/Board Member | |
Schering-Plough Holdings Ltd.
 Schering-Plough Holdings Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Holdings Ltd. develops and manufactures pharmaceutical products. It offers sterilization tablets, cotton buds, and animal & veterinary health products. The company is headquartered in Welwyn Garden City, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Nanjing University | College/University | Graduate Degree Undergraduate Degree | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree | |
International Biomedical Research Alliance
 International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | Miscellaneous Commercial Services | Director/Board Member | |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
| Chengdu University of Technology | College/University | Undergraduate Degree | |
GenScript Corp.
 GenScript Corp. BiotechnologyHealth Technology GenScript Corp. provides biological research and drug discovery services to pharmaceutical companies. Its products include antibodies, recombinant proteins, protein isolation and analysis, molecular biology reagents, peptides, and cell lines. It offers life sciences research services and preclinical drug development services. The company was founded by Ye Wang, Fang Liang Zhang, and Lu Quan Wang in 2002 and is headquartered in Piscataway, NJ. | Biotechnology | Chief Executive Officer | |
Interuniversitair Micro-Electronica Centrum VZW
 Interuniversitair Micro-Electronica Centrum VZW Miscellaneous Commercial ServicesCommercial Services Interuniversitair Micro-Electronica Centrum VZW, also known as Imec, is a Belgian business accelerator. The non-profit company is based in Leuven, BE and has subsidiaries in the United States, Taiwan, India, Netherlands, and Belgium. Imec.istart is their main program, which helps startups grow and succeed. The Belgian company was founded in 1984 and has been led by CEO Luc van den Hove since then. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Antwerp | College/University | Graduate Degree | |
NantWorks LLC
 NantWorks LLC Information Technology ServicesTechnology Services NantWorks LLC develops technology based semiconductor and advanced networks for healthcare improvements. Its solution is for life threatening diseases such as cancer, infectious diseases and Alzheimer’s. The company was founded by Patrick Soon-Shiong in September 2011 and is headquartered in Culver City, CA. | Information Technology Services | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
GenScript (Hong Kong) Ltd.
 GenScript (Hong Kong) Ltd. Medical/Nursing ServicesHealth Services Part of Genscript Biotech Corp., GenScript (Hong Kong) Ltd. provides diagnostic services for medical professionals. The company is based in Hong Kong, Hong Kong. | Medical/Nursing Services | Director/Board Member | |
CLEARink Displays, Inc.
 CLEARink Displays, Inc. Financial ConglomeratesFinance CLEARink Displays, Inc. develops reflective display modules for electronic shelf labels, wearables, mobile devices, smartphones and tablets, and outdoor signage applications. The company was founded by Frank Christiaens in 2012 and is headquartered in Fremont, CA. | Financial Conglomerates | Director/Board Member | |
| GENSCRIPT BIOTECH CORPORATION | Biotechnology | Director/Board Member | |
ELIX Wireless Charging Systems, Inc.
 ELIX Wireless Charging Systems, Inc. Electrical ProductsProducer Manufacturing ELIX Wireless Charging Systems, Inc. provides electrical wireless power transfer to charging electric vehicles. It presently offering customers the following products (charging power): E1K (1 kW), E8K (7.7 kW), E10K (10 kW), E40K (40 kW). The company was founded by Frank Christiaens in 2013 and is headquartered in Vancouver, Canada. | Electrical Products | Director/Board Member | |
| Nanjing Jinsirui Biotechnology Co., Ltd. | Director/Board Member | ||
| Jinsikang Technology (Nanjing) Co., Ltd. | Director/Board Member | ||
Nanjing Bestzyme Bioengineering Co., Ltd.
 Nanjing Bestzyme Bioengineering Co., Ltd. BiotechnologyHealth Technology Nanjing Bestzyme Bioengineering Co., Ltd. provides biological research and drug discovery services to pharmaceutical companies. The joint venture company is based in Nanjing, China. and has subsidiaries in China. | Biotechnology | Director/Board Member | |
| Hubei Bestzyme Biotechnology Co. Ltd. | Director/Board Member | ||
| Shanghai Jingrui Biotechnology Co. Ltd. | Director/Board Member | ||
| Bestzyme Biotech Corp. | Director/Board Member | ||
| Bestzyme Biotech Hk Ltd. | Director/Board Member | ||
| Bestzyme Biotech Ltd. | Director/Board Member | ||
| Bestzyme Biotech USA, Inc. | Director/Board Member | ||
Nanjing Legend Biotechnology Co., Ltd.
 Nanjing Legend Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Genscript Biotech Corp., Nanjing Legend Biotech Co., Ltd. is a commercial-stage biotechnology company that develops, manufactures, and commercializes novel therapies. Nanjing Legend Biotech Co., Ltd. is based in Nanjing, China. Nanjing Legend Biotech is fiercely pursuing and delivering therapies, creating new hope and new opportunities, and transforming the world of oncology and medicine. Nanjing Legend Biotech is dedicated to exploring the potential of cell therapies to treat diseases that are considered intractable and incurable, particularly hematological malignancies and solid tumors. The Chinese company is currently focused on discovering and developing a broad portfolio of cell therapies to strengthen patients' immune systems and fight diseases. The company's pipeline includes innovative technologies such as autologous chimeric antigen receptor T-cell therapy (CAR-T), allogeneic non-gene-editing CAR-T, natural killer (NK) cells, and CAR-?? T cells. | Miscellaneous Commercial Services | Director/Board Member | |
| Legend Biotech HK Ltd. | Director/Board Member | ||
| Legend Biotech Ltd. | Director/Board Member | ||
| Genscript Biotech Ltd. | Director/Board Member | ||
| GenScript International Ltd. | Director/Board Member | ||
GenScript USA, Inc.
 GenScript USA, Inc. Medical SpecialtiesHealth Technology GenScript USA, Inc. engages in the provision of life science research services. The company is headquartered in United States. | Medical Specialties | Director/Board Member | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| INVIVYD, INC. | Biotechnology | Director/Board Member | |
| IMMUNITYBIO, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| Interlaken Therapeutics, Inc. | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 27 |
| Cina | 10 |
| Belgio | 5 |
| Hong Kong | 5 |
| Paesi Bassi | 2 |
Settori
| Health Technology | 22 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Finance | 3 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 88 |
| Corporate Officer/Principal | 42 |
| Chairman | 32 |
| Chief Executive Officer | 23 |
| Independent Dir/Board Member | 19 |
Contatti più connessi
| Insiders | |
|---|---|
| Patrick Soon-Shiong | 52 |
| Michael Blaszyk | 24 |
| Fang Liang Zhang | 24 |
| Kirk Calhoun | 23 |
| Tomas Jan Heyman | 18 |
| Nashina Asaria | 10 |
| Li Mao | 8 |
| Meeta Chatterjee | 7 |
| Brandon Villery | 7 |
| Mythili Koneru | 6 |
| Guowei Fang | 5 |
| Arlyn Small | 5 |
| Bob Petrou | 5 |
| Robert Sexton | 4 |
| Lida Pacaud | 3 |
- Borsa valori
- Insiders
- Marc L. Harrison
- Connessioni Società
